DRIO (DarioHealth) Cyclically Adjusted Revenue per Share: $87.17 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DRIO DarioHealth Corp DRIO
56 GF Score
Price $7.29
GF Value $4.44
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is DarioHealth Cyclically Adjusted Revenue per Share?

DarioHealth DRIO +8.86% 56 Cyclically Adjusted Revenue per Share is $87.17 as of Jun. 2026. GuruFocus rates DRIO with a GF Score™ of 56/100 and a GF Value™ of $4.44 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

DarioHealth's adjusted revenue per share for the three months ended in Jun. 2026 was $0.554. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $87.17 for the trailing ten years ended in Jun. 2026.

During the past 12 months, DarioHealth's average Cyclically Adjusted Revenue Growth Rate was -22.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of DarioHealth was -5.80% per year. The lowest was -9.70% per year. And the median was -7.75% per year.

As of today (2026-09-01), DarioHealth's current stock price is $7.29. DarioHealth's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $87.17. DarioHealth's Cyclically Adjusted PS Ratio of today is 0.08.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DarioHealth was 1.84. The lowest was 0.06. And the median was 0.21.


DarioHealth  (NAS:DRIO) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DarioHealth's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7.29/87.17
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DarioHealth was 1.84. The lowest was 0.06. And the median was 0.21.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


DarioHealth Cyclically Adjusted Revenue per Share Related Terms


DarioHealth Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for DarioHealth's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DarioHealth Cyclically Adjusted Revenue per Share Chart

DarioHealth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 141.20 135.13 126.13 118.03 99.46

DarioHealth Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 112.17 105.66 99.46 92.68 87.17

DRIO vs VASO, ONMD, CCLD: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, DarioHealth's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DarioHealth Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DarioHealth's Cyclically Adjusted PS Ratio falls into.


DRIO
56GF Score
DarioHealth Corp DRIO
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DarioHealth Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DarioHealth's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.554/333.9520*333.9520
=0.554

Current CPI (Jun. 2026) = 333.9520.

DarioHealth Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 52.000 241.428 71.928
201612 59.857 241.432 82.795
201703 55.944 243.801 76.631
201706 50.417 244.955 68.734
201709 55.000 246.819 74.416
201712 54.414 246.524 73.712
201803 47.459 249.554 63.509
201806 41.180 251.989 54.574
201809 31.847 252.439 42.130
201812 19.767 251.233 26.275
201903 24.370 254.202 32.016
201906 15.575 256.143 20.306
201909 14.709 256.759 19.131
201912 21.153 256.974 27.489
202003 10.755 258.115 13.915
202006 8.675 257.797 11.238
202009 5.579 260.280 7.158
202012 5.123 260.474 6.568
202103 5.128 264.877 6.465
202106 6.702 271.696 8.238
202109 6.831 274.310 8.316
202112 6.788 278.802 8.131
202203 8.215 287.504 9.542
202206 5.516 296.311 6.217
202209 5.748 296.808 6.467
202212 5.254 296.797 5.912
202303 5.123 301.836 5.668
202306 4.366 305.109 4.779
202309 2.441 307.789 2.648
202312 2.502 306.746 2.724
202403 3.344 312.332 3.575
202406 3.140 314.175 3.338
202409 3.673 315.301 3.890
202412 3.962 315.605 4.192
202503 2.850 319.799 2.976
202506 2.163 322.561 2.239
202509 1.596 324.800 1.641
202512 0.757 324.054 0.780
202603 0.848 330.213 0.858
202606 0.554 333.952 0.554

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $87.17 mean?
DarioHealth (DRIO) has a Cyclically Adjusted Revenue per Share of $87.17 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on DarioHealth and its competitors.
Is DarioHealth's Cyclically Adjusted Revenue per Share too high?
DarioHealth's current Cyclically Adjusted Revenue per Share is $87.17. Overall, DarioHealth has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's Cyclically Adjusted Revenue per Share compare to VASO and ONMD?
DarioHealth's Cyclically Adjusted Revenue per Share of $87.17 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on DarioHealth and its competitors. DarioHealth's current Cyclically Adjusted Revenue per Share is $87.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.44, compared to a current price of $7.29 — trading 64.2% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $87.17. DarioHealth's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For DarioHealth (DRIO), the current Cyclically Adjusted Revenue per Share is $87.17 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DarioHealth (DRIO) Overvalued in 2026?

Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued. The current stock price of $7.29 is trading 64.2% above its estimated GF Value™ of $4.44. GuruFocus considers DarioHealth to be Significantly Overvalued.

Key valuation signals for DRIO:

  • Cyclically Adjusted Revenue per Share: $87.17
  • GF Value™: $4.44 vs. price of $7.29 (64.2% above fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DarioHealth Business Description

Address 322 West 57th Street, New York, NY, USA, 10019
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
56GF Score

Get the complete analysis for DRIO

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.29
Price
$4.44
GF Value